Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00295776 · ClinicalTrials.gov registry record · Phase 2
Lamictal in the Treatment of Post-Herpetic Neuralgia
A Phase 2 study, sponsored by George Washington University.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00295776: Clinical Trial Phase 2 study, sponsored by George Washington University.
NCT00295776 is a Phase 2 study that was terminated before completion, run by George Washington University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00295776, a Phase 2 study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
To assess the efficacy of Lamictal for the treatment of pain and reduction of allodynia in patients with post herpetic neuralgia.
Interventions
- DRUG Lamictal in the treatment of Post-Herpetic Neuralgia
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-02 |
| Phase | Phase 2 |
Why NCT00295776 stopped before completion
NCT00295776 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Lamictal in the treatment of Post-Herpetic Neuralgia is the first listed.
NCT00295776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00295776 about?
NCT00295776 is a clinical study titled "Lamictal in the Treatment of Post-Herpetic Neuralgia". To assess the efficacy of Lamictal for the treatment of pain and reduction of allodynia in patients with post herpetic neuralgia.
What is the current status of trial NCT00295776?
This trial is currently terminated. It is a Phase 2 study. The study started on 2005-02.
What interventions are being tested in trial NCT00295776?
The interventions under investigation include: Lamictal in the treatment of Post-Herpetic Neuralgia (DRUG).
Who is sponsoring clinical trial NCT00295776?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia